These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9893360)
21. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680 [TBL] [Abstract][Full Text] [Related]
22. Cholera toxin and related enterotoxins: a cell biological and immunological perspective. de Haan L; Hirst TR J Nat Toxins; 2000 Aug; 9(3):281-97. PubMed ID: 10994530 [TBL] [Abstract][Full Text] [Related]
23. Roadblocks in the gut: barriers to enteric infection. Gill N; Wlodarska M; Finlay BB Cell Microbiol; 2011 May; 13(5):660-9. PubMed ID: 21392202 [TBL] [Abstract][Full Text] [Related]
25. Determination of tolerable fatty acids and cholera toxin concentrations using human intestinal epithelial cells and BALB/c mouse macrophages. Tamari F; Tychowski J; Lorentzen L J Vis Exp; 2013 May; (75):e50491. PubMed ID: 23748896 [TBL] [Abstract][Full Text] [Related]
26. Current status of cholera and rise of novel mucosal vaccine. Yamamoto T Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702 [TBL] [Abstract][Full Text] [Related]
28. Possibilities of immunization against cholera and related enterotoxic enteropathies. Finkelstein RA Dev Biol Stand; 1976; 33():102-7. PubMed ID: 955264 [TBL] [Abstract][Full Text] [Related]
29. Host/pathogen interactions at mucosal surfaces: immune consequences. Clare S; Huett A; Dougan G Res Microbiol; 2002 Sep; 153(7):455-9. PubMed ID: 12405353 [TBL] [Abstract][Full Text] [Related]
30. Telling apart friend from foe: discriminating between commensals and pathogens at mucosal sites. Srinivasan N Innate Immun; 2010 Dec; 16(6):391-404. PubMed ID: 20083498 [TBL] [Abstract][Full Text] [Related]
32. Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut. Qadri F; Bhuiyan TR; Dutta KK; Raqib R; Alam MS; Alam NH; Svennerholm AM; Mathan MM Gut; 2004 Jan; 53(1):62-9. PubMed ID: 14684578 [TBL] [Abstract][Full Text] [Related]
33. Induction of immunomodulatory miR-146a and miR-155 in small intestinal epithelium of Vibrio cholerae infected patients at acute stage of cholera. Bitar A; De R; Melgar S; Aung KM; Rahman A; Qadri F; Wai SN; Shirin T; Hammarström ML PLoS One; 2017; 12(3):e0173817. PubMed ID: 28319200 [TBL] [Abstract][Full Text] [Related]
34. Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit. Lewis DJ; Castello-Branco LR; Novotny P; Dougan G; Poulton TA; Griffin GE Vaccine; 1993; 11(2):119-21. PubMed ID: 8438610 [TBL] [Abstract][Full Text] [Related]
35. Regulation of the polymeric immunoglobulin receptor in intestinal epithelial cells by Enterobacteriaceae: implications for mucosal homeostasis. Bruno ME; Rogier EW; Frantz AL; Stefka AT; Thompson SN; Kaetzel CS Immunol Invest; 2010; 39(4-5):356-82. PubMed ID: 20450283 [TBL] [Abstract][Full Text] [Related]
36. The role of antigen form and the induction of an intestinal immune response to cholera toxin/toxoid in rats. Pierce NF Adv Exp Med Biol; 1978; 107():439-45. PubMed ID: 742499 [No Abstract] [Full Text] [Related]
37. Sequential changes in gut mucosa of rabbits infected with Vibrio cholerae O139 Bengal: an ultrastructural study. Saha DR; Koley H; Ghosh AN; Nair GB J Diarrhoeal Dis Res; 1997 Jun; 15(2):59-64. PubMed ID: 9360342 [TBL] [Abstract][Full Text] [Related]
39. A review of the current status of enteric vaccines. Levine MM; Noriega F P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876 [TBL] [Abstract][Full Text] [Related]